Key result
Small-diameter BioLAB xenopericardial prostheses show ~6% hospital mortality in older patients undergoing aortic valve replacement.
Why the study?
The safety and effectiveness of small-diameter BioLAB xenopericardial prostheses in aortic valve position in elderly patients required investigation, including the impact of prosthesis-patient mismatch on transvalvular pressure gradients related to body size.
Observational (n=65)
No
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for small-diameter BioLAB prostheses in older aortic patients; prospective trials needed before wider adoption.
A prosthesis-patient mismatch (PPM) describes a state in which the valve prosthesis implanted during surgery is too small in relation to the patient’s body size. This leads to high transvalvular pressure gradients. We investigate direct results and dependence of transvalvular pressure gradients on body mass index and surface area in patients after correction of aortic valve defects using small-diameter BioLAB prosthesis. Material and methods . From January 2011 to August 2018, 65 small-diameter (18, 20) BioLAB scaffold xenopericardial prostheses were implanted in aortic position at the Department of Emergency Surgery for Acquired Heart Defects, Bakulev National Medical Research Center of Cardiovascular Surgery. The average age of the patients was 75.4 ± 4.1 (65–86 years). The average patient body mass index was 25.74 ± 5.11 kg/m2 (19.57–39.54). The average body surface area was 1.79 ± 0.15 (1.54–2.18). Results . Isolated aortic valve replacement was performed in 38 (58%) patients, the rest of the surgeries were combined with other techniques. There were no reoperations due to early prosthetic endocarditis or prosthetic dysfunction in hospital. Hospital mortality was 6% (4 patients). Correlation dependence of peak pressure prosthesis gradient on body surface area and body mass index was 10% and 8%, respectively. Conclusions . This study confirmed the safety and effectiveness of using small-diameter BioLAB scaffold xenopericardial prostheses in aortic valve position.
No takes yet. Share an insight, caveat, or question.
Babenko et al. (2020) conducted an observational in Aortic valve defects (n=65). BioLAB xenopericardial prosthesis (small-diameter) was evaluated on Hospital mortality. Correction of aortic valve defects using small-diameter BioLAB xenopericardial prostheses in older patients resulted in a 6% hospital mortality and a weak correlation of peak pressure gradients with body surface area and body mass index.
Synapse has enriched 10 related papers. Consider them for comparative context: